Live Breaking News & Updates on Nanobiotix Company Profile Get Rating

Stay updated with breaking news from Nanobiotix company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analyzing Revance Therapeutics (NASDAQ:RVNC) and Nanobiotix (NASDAQ:NBTX)

Revance Therapeutics (NASDAQ:RVNC – Get Rating) and Nanobiotix (NASDAQ:NBTX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability. Institutional and Insider Ownership 79.9% of Revance Therapeutics shares are […] ....

United States , France General , South Korea , Revance Therapeutics Company Profile Get Rating , Nanobiotix Company Profile Get Rating , Revance Therapeutics Inc , Essentia Biosystems Inc , Viatris Inc , Revance Therapeutics , Get Rating , Given Revance Therapeutic , Therapeutics Company Profile , Essentia Biosystems , Company Profile , Greater China , Nasdaq Rvnc , Stock Comparison , Stock Analysis ,

Reviewing Nanobiotix (NASDAQ:NBTX) & DiaMedica Therapeutics (NASDAQ:DMAC)

Nanobiotix (NASDAQ:NBTX – Get Rating) and DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk. Risk and Volatility Nanobiotix has a beta of 0.61, indicating […] ....

United States , France General , South Korea , Diamedica Therapeutics Company Profile Get Rating , Nanobiotix Company Profile Get Rating , Diamedica Inc , Diamedica Therapeutics Inc , Get Rating , Diamedica Therapeutics , Medica Therapeutics , Given Diamedica Therapeutic , Diamedica Therapeutic , Company Profile , Greater China , Medica Therapeutics Company Profile , Medica Therapeutics Inc , Nasdaq Nbtx , Stock Comparison , Stock Analysis ,

Nanobiotix S.A. (NASDAQ:NBTX) Short Interest Down 44.4% in May

Nanobiotix S.A. (NASDAQ:NBTX – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,000 shares, a decrease of 44.4% from the April 30th total of 1,800 shares. Based on an average daily trading volume, of 1,600 shares, the […] ....

Nanobiotix Company Profile Get Rating , Zacks Investment Research , Get Rating , Company Profile , Nasdaq Nbtx ,

Zacks Investment Research Lowers Nanobiotix (NASDAQ:NBTX) to Hold

Nanobiotix (NASDAQ:NBTX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Nanobiotix S.A. is a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer. The company’s proprietary technology includes NBTXR3. Nanobiotix S.A. is headquartered […] ....

France General , Nanobiotix Company Profile Get Rating , Zacks Investment Research , Get Rating , Company Profile , Nasdaq Nbtx ,

Nanobiotix S.A. (NASDAQ:NBTX) Short Interest Up 30.0% in March

Nanobiotix S.A. (NASDAQ:NBTX – Get Rating) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 1,300 shares, an increase of 30.0% from the February 28th total of 1,000 shares. Based on an average trading volume of 6,000 shares, the short-interest ratio is currently […] ....

Nanobiotix Company Profile Get Rating , Get Rating , Company Profile , Nasdaq Nbtx ,